The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2,4-Difluoro-N-(2-methoxy-5-(3-oxo-4-(3-(2-oxopyridin-1(2H)-yl)propyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)pyridin-3-yl)benzenesulfonamide ID: ALA4239797
PubChem CID: 145983736
Max Phase: Preclinical
Molecular Formula: C28H24F2N4O6S
Molecular Weight: 582.59
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ncc(-c2ccc3c(c2)N(CCCn2ccccc2=O)C(=O)CO3)cc1NS(=O)(=O)c1ccc(F)cc1F
Standard InChI: InChI=1S/C28H24F2N4O6S/c1-39-28-22(32-41(37,38)25-9-7-20(29)15-21(25)30)13-19(16-31-28)18-6-8-24-23(14-18)34(27(36)17-40-24)12-4-11-33-10-3-2-5-26(33)35/h2-3,5-10,13-16,32H,4,11-12,17H2,1H3
Standard InChI Key: SXTQMACHLBBJDO-UHFFFAOYSA-N
Molfile:
RDKit 2D
41 45 0 0 0 0 0 0 0 0999 V2000
11.9954 -12.8412 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.4121 -12.1288 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
11.5867 -12.1242 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.4162 -13.7829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4162 -14.6079 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.1282 -15.0161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8402 -14.6079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8402 -13.7829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1282 -13.3662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5537 -15.0248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5504 -15.8507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2602 -16.2641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2666 -14.6123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9808 -15.0303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9742 -15.8580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6836 -16.2752 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.4043 -15.8695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4110 -15.0419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6970 -14.6200 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.1292 -14.6358 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.1282 -12.5413 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.4138 -11.3038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1350 -10.8925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1354 -10.0684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4204 -9.6609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7036 -10.0720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7067 -10.8949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7006 -13.3725 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.9873 -13.7870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7025 -13.7950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4197 -13.3873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8483 -11.3072 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12.4192 -8.8385 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
17.4253 -12.5624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1424 -12.1546 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.8563 -12.5772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5713 -12.1730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5811 -11.3477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8696 -10.9283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1483 -11.3341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8480 -13.4022 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 1 0
4 9 2 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
10 11 1 0
10 13 2 0
11 12 2 0
12 15 1 0
14 13 1 0
7 10 1 0
14 15 2 0
14 19 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
18 20 2 0
9 21 1 0
21 2 1 0
2 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
4 28 1 0
28 29 1 0
19 30 1 0
30 31 1 0
23 32 1 0
25 33 1 0
31 34 1 0
34 35 1 0
35 36 1 0
35 40 1 0
36 37 1 0
37 38 2 0
38 39 1 0
39 40 2 0
36 41 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 582.59Molecular Weight (Monoisotopic): 582.1385AlogP: 3.81#Rotatable Bonds: 9Polar Surface Area: 119.83Molecular Species: NEUTRALHBA: 8HBD: 1#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 6.58CX Basic pKa: 0.77CX LogP: 2.39CX LogD: 1.75Aromatic Rings: 4Heavy Atoms: 41QED Weighted: 0.32Np Likeness Score: -1.96
References 1. Dong FD, Liu DD, Deng CL, Qin XC, Chen K, Wang J, Song HR, Ding HW.. (2018) Design, synthesis and biological evaluation of novel series of 2H-benzo[b][1,4]oxazin-3(4H)-one and 2H-benzo[b][1,4]oxazine scaffold derivatives as PI3Kα inhibitors., 26 (14): [PMID:29937355 ] [10.1016/j.bmc.2018.06.022 ]